{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:48:10Z","timestamp":1791478090074,"version":"4.3.4"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>This systematic review aims to evaluate the use of intrathecal baclofen (ITB) for hereditary spastic paraparesis (HSP) treatment. An extensive search in two electronical databases was performed. We identified articles published between 1990 and 2022 (PubMed, Scopus), and applied the following inclusion criteria: diagnosis of HSP at the time of the intervention, either familial or sporadic; report on the effect of ITB in patients with HSP; test trial via either bolus injections or continuous infusion tests; and ITB pump implantation. A data extraction sheet based on the Cochrane Consumers and Communication Review Group\u2019s data extraction template was created and adapted to collect relevant data. A qualitative analysis was performed to present the results in narrative summary fashion. A total of 6 studies met our inclusion criteria. 51 patients with HSP had a pre-implantation ITB trial. The time since the diagnosis until the pump implantation ranged from 5 to 30 years. The initial bolus ranged from 20 to 50\u2005\u03bcg and the mean doses used at steady state ranged from 65 to 705\u2005\u03bcg. An improvement in spasticity was observed on the modified Ashworth Scale in patients treated with ITB. Although all studies reported a subjective gait improvement, not all found an objective improvement in gait. The most common side effect reported was catheter-related problems. The findings of this review support the use of ITB as an effective and a viable option for the treatment of spasticity in HSP refractory to conservative therapies.<\/jats:p>","DOI":"10.1097\/mrr.0000000000000607","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T10:00:34Z","timestamp":1705917634000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Intrathecal baclofen for the management of hereditary spastic paraparesis: a systematic review"],"prefix":"10.1097","volume":"47","author":[{"given":"Luisa","family":"Viana Pinto","sequence":"first","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Romeiro","sequence":"additional","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Gouveia","sequence":"additional","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Ramalho","sequence":"additional","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ribeiro Silva","sequence":"additional","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria In\u00eas","family":"T\u00e1boas Sim\u00f5es","sequence":"additional","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Rodrigues Leal","sequence":"additional","affiliation":[{"name":"Department of Physical and Rehabilitation Medicine, Centro Hospitalar de Entre o Douro e Vouga, Santa Maria da Feira, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,20]]},"reference":[{"key":"R1-20250525","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/jnnp.44.10.871","article-title":"Hereditary \u2018pure\u2019 spastic paraplegic: clinical and genetic study of 22 families.","volume":"44","author":"Harding","year":"1981","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R2-20250525","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1055\/s-2008-1041143","article-title":"Hereditary spastic paraplegias.","volume":"13","author":"Harding","year":"1993","journal-title":"Semin Neurol"},{"key":"R3-20250525","first-page":"794","article-title":"Intrathecal baclofen in hereditary spastic paraparesis.","volume":"73","author":"Meythaler","year":"1992","journal-title":"Arch Phys Med Rehabil"},{"key":"R4-20250525","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1517\/14656566.7.14.1849","article-title":"Hereditary spastic paraplegia: clinical genomics and pharmacogenetic perspectives.","volume":"7","author":"Contino","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"R5-20250525","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fneur.2019.00003","article-title":"Management of hereditary spastic paraplegia: a systematic review of the literature.","volume":"10","author":"Bellofatto","year":"2019","journal-title":"Front Neurol"},{"key":"R6-20250525","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrn2946","article-title":"Hereditary spastic paraplegias: membrane traffic and the motor pathway.","volume":"12","author":"Blackstone","year":"2011","journal-title":"Nat Rev Neurosci"},{"key":"R7-20250525","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejpn.2021.11.003","article-title":"The use of intrathecal baclofen for management of spasticity in hereditary spastic paraparesis: a case series.","volume":"36","author":"Pointon","year":"2022","journal-title":"Eur J Paediatr Neurol"},{"key":"R8-20250525","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00702-015-1425-1","article-title":"Intrathecal baclofen therapy in Germany: proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.","volume":"122","author":"Dressler","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"key":"R9-20250525","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/jnnp.69.2.150","article-title":"Hereditary spastic paraparesis: a review of new developments.","volume":"69","author":"McDermott","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R10-20250525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1615\/CritRevPhysRehabilMed.2013007945","article-title":"A review of spasticity treatments: pharmacological and interventional approaches.","volume":"25","author":"Chang","year":"2013","journal-title":"Crit Rev Phys Rehabil Med"},{"key":"R11-20250525","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0987-7053(00)88866-8","article-title":"Intrathecal baclofen normalizes motor strategy for squatting in familial spastic paraplegia: a case study.","volume":"30","author":"Dan","year":"2000","journal-title":"Neurophysiol Clin"},{"key":"R12-20250525","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1161\/hs0901.095682","article-title":"Intrathecal baclofen for spastic hypertonia from stroke.","volume":"32","author":"Meythaler","year":"2001","journal-title":"Stroke"},{"key":"R13-20250525","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3389\/fneur.2019.00901","article-title":"Intrathecal baclofen in hereditary spastic paraparesis.","volume":"10","author":"Pucks-Faes","year":"2019","journal-title":"Front Neurol"},{"key":"R14-20250525","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/CA.S91140","article-title":"Use of continuous intrathecal baclofen in hereditary spastic paraplegia.","volume":"7","author":"Andrew","year":"2015","journal-title":"Clin Audit"},{"key":"R15-20250525","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R16-20250525","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.PHM.0000156892.04239.B6","article-title":"Instrumental evaluation of gait modifications before and during intrathecal baclofen therapy: a 2-year follow-up case study.","volume":"84","author":"Molteni","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"key":"R17-20250525","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.apmr.2015.01.012","article-title":"Improved gait performance in a patient with hereditary spastic paraplegia after a continuous intrathecal baclofen test infusion and subsequent pump implantation: a case report.","volume":"96","author":"Heetla","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"key":"R18-20250525","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.annrmp.2007.02.009","article-title":"Intrathecal baclofen in hereditary spastic paraparesis: benefits and limitations.","volume":"50","author":"Lambrecq","year":"2007","journal-title":"Ann Readapt Med Phys"},{"key":"R19-20250525","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.clineuro.2014.05.024","article-title":"Intrathecal baclofen therapy for the symptomatic treatment of hereditary spastic paraplegia.","volume":"123","author":"Margetis","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"R20-20250525","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00381-020-04736-x","article-title":"Intrathecal baclofen for hereditary spastic paraplegia (HSP).","volume":"36","author":"Coulter","year":"2020","journal-title":"Childs Nerv Syst"},{"key":"R21-20250525","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/ner.12437","article-title":"Best practices for intrathecal baclofen therapy: screening test.","volume":"19","author":"Boster","year":"2016","journal-title":"Neuromodulation"},{"key":"R22-20250525","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1007\/s10143-021-01550-0","article-title":"Intrathecal baclofen, selective dorsal rhizotomy, and extracorporeal shockwave therapy for the treatment of spasticity in cerebral palsy: a systematic review.","volume":"44","author":"Kudva","year":"2021","journal-title":"Neurosurg Rev"},{"key":"R23-20250525","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/2045772313Y.0000000102","article-title":"Examining the effectiveness of intrathecal baclofen on spasticity in individuals with chronic spinal cord injury: a systematic review.","volume":"37","author":"McIntyre","year":"2014","journal-title":"J Spinal Cord Med"},{"key":"R24-20250525","doi-asserted-by":"crossref","first-page":"20503121211022197","DOI":"10.1177\/20503121211022197","article-title":"Baclofen therapeutics, toxicity, and withdrawal: a narrative review.","volume":"9","author":"Romito","year":"2021","journal-title":"SAGE Open Med"},{"key":"R25-20250525","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/archdischild-2020-319878","article-title":"Is intrathecal baclofen an effective treatment for children with hereditary spastic paraparesis?","volume":"105","author":"Pointon","year":"2020","journal-title":"Arch Dis Child"},{"key":"R26-20250525","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MRR.0000000000000586","article-title":"Twenty years of intrathecal baclofen therapy in Slovenia: a retrospective single-center analysis of complications.","volume":"46","author":"Benedi\u010di\u010d","year":"2023","journal-title":"Int J Rehabil Res"}],"container-title":["International Journal of Rehabilitation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MRR.0000000000000607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T20:03:16Z","timestamp":1748203396000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MRR.0000000000000607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mrr.0000000000000607","relation":{},"ISSN":["0342-5282"],"issn-type":[{"value":"0342-5282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,20]]}}}